Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume $10.57 +0.23 (+2.22%) As of 08/1/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Astellas Pharma Short Interest DataAstellas Pharma (ALPMY) has a short interest of 350,400 shares. This marks a 1,252.90% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 216,877 shares to cover all short positions.Current Short Interest350,400 sharesPrevious Short Interest25,900 sharesChange Vs. Previous Month+1,252.90%Dollar Volume Sold Short$3.38 millionShort Interest Ratio0.7 Days to CoverLast Record DateJuly 15, 2025Today's Trading Volume268,036 sharesAverage Trading Volume216,877 sharesToday's Volume Vs. Average124% Short Selling Astellas Pharma? Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPMY Short Interest Over TimeALPMY Days to Cover Over TimeALPMY Percentage of Float Shorted Over Time Astellas Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025350,400 shares $3.38 million +1,252.9%N/A0.7 $9.66 6/30/202525,900 shares $252.53 thousand -44.5%N/A0.1 $9.75 6/15/202546,700 shares $449.72 thousand -25.8%N/A0.2 $9.63 5/31/202562,900 shares $616.11 thousand +555.2%0.0%0.3 $9.80 5/15/20259,600 shares $87.84 thousand -62.9%0.0%0 $9.15 4/30/202525,900 shares $256.67 thousand +2,777.8%N/A0.1 $9.91 4/15/2025900 shares $8.35 thousand -98.5%0.0%0 $9.28 3/31/202560,400 shares $582.71 thousand +144.5%0.0%0.4 $9.65 3/15/202524,700 shares $244.28 thousand -56.7%0.0%0.1 $9.89 2/28/202557,000 shares $553.47 thousand +20.8%0.0%0.3 $9.71 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/15/202547,200 shares $461.14 thousand -49.0%0.0%0.1 $9.77 1/31/202592,500 shares $895.40 thousand +132.4%N/A0.2 $9.68 1/15/202539,800 shares $385.86 thousand +26.4%N/A0.1 $9.70 12/31/202431,500 shares $304.29 thousand -58.7%N/A0 $9.66 12/15/202476,200 shares $768.10 thousand +150.7%N/A0.1 $10.08 11/30/202430,400 shares $315.55 thousand -69.8%N/A0.1 $10.38 11/15/2024100,500 shares $1.08 million +1,004.4%N/A0.3 $10.70 10/31/20249,100 shares $106.29 thousand -79.8%N/A0.1 $11.68 10/15/202445,100 shares $517.30 thousand +16.2%N/A0.2 $11.47 9/30/202438,800 shares $444.26 thousand +269.5%N/A0.3 $11.45 9/15/202410,500 shares $126.11 thousand -75.4%N/A0.1 $12.01 8/31/202442,600 shares $528.67 thousand +38.8%N/A0.3 $12.41 8/15/202430,700 shares $351.21 thousand -89.7%N/A0.1 $11.44 7/31/2024298,700 shares $3.47 million -11.9%N/A0.6 $11.61 7/15/2024338,900 shares $3.53 million +48.8%N/A1 $10.42 6/30/2024227,800 shares $2.25 million -10.5%N/A0.4 $9.86 6/15/2024254,500 shares $2.42 million +83.5%N/A0.3 $9.51 5/31/2024138,700 shares $1.36 million +87.2%N/A0.2 $9.81 5/15/202474,100 shares $726.18 thousand -11.7%N/A0.1 $9.80 4/30/202483,900 shares $801.25 thousand +20.2%N/A0.1 $9.55 4/15/202469,800 shares $647.15 thousand -59.4%N/A0.1 $9.27 3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75 3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83 2/29/202474,000 shares $808.82 thousand +9.1%N/A0.2 $10.93 2/15/202467,800 shares $749.19 thousand -19.7%N/A0.1 $11.05 1/15/202468,200 shares $823.86 thousand -57.1%N/A0.2 $12.08 12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90 12/15/202339,200 shares $445.31 thousand -14.6%N/A0 $11.36 11/30/202345,900 shares $558.14 thousand -7.8%N/A0.1 $12.16 11/15/202349,800 shares $579.92 thousand +3.8%N/A0.1 $11.65The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 10/31/202348,000 shares $609.12 thousand +1,197.3%N/A0.1 $12.69 10/15/20233,700 shares $48.25 thousand -27.5%N/A0 $13.04 9/30/20235,100 shares $70.64 thousand -54.1%N/A0 $13.85 9/15/202311,100 shares $165.50 thousand -74.7%N/A0 $14.91 8/31/202343,900 shares $664.65 thousand -43.9%N/A0.2 $15.14 8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13 7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63 7/15/202364,800 shares $933.12 thousand +9,157.1%N/A0.2 $14.40 6/30/2023700 shares $10.41 thousand -98.3%N/A0 $14.87 6/15/202340,900 shares $659.31 thousand -32.2%N/A0.5 $16.12 5/31/202360,300 shares $950.93 thousand +61.2%N/A0.3 $15.77 5/15/202337,400 shares $599.52 thousand +77.3%N/A0.4 $16.03 4/30/202321,100 shares $316.92 thousand +64.8%N/A0.3 $15.02 4/15/202312,800 shares $189.57 thousand -60.7%N/A0.1 $14.81 3/31/202332,600 shares $462.76 thousand -26.4%N/A0.2 $14.20 3/15/202344,300 shares $610.01 thousand -15.8%N/A0.2 $13.77 2/28/202352,600 shares $736.40 thousand +310.9%N/A0.2 $14.00 2/15/202312,800 shares $183.94 thousand +75.3%N/A0.1 $14.37 1/31/20237,300 shares $107.16 thousand -73.7%N/A0 $14.68 1/15/202327,700 shares $404.97 thousand -43.7%N/A0.2 $14.62 12/30/202249,200 shares $745.87 thousand +278.5%N/A0.5 $15.16 12/15/202213,000 shares $202.41 thousand -75.8%N/A0.2 $15.57 11/30/202253,600 shares $828.66 thousand -48.9%N/A0.5 $15.46 11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07 10/31/202255,700 shares $772.00 thousand -50.2%N/A0.2 $13.86 10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33 9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33 9/15/202216,500 shares $227.21 thousand No ChangeN/A0 $13.77 8/15/20222,000 shares $30.60 thousand -95.6%N/A0 $15.30 7/31/202245,100 shares $702.21 thousand -32.5%N/A0.2 $15.57 7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82 6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56 6/15/202239,200 shares $587.22 thousand +1,087.9%N/A0.2 $14.98 5/31/20223,300 shares $52.50 thousand -85.3%N/A0 $15.91 5/15/202222,400 shares $339.36 thousand -62.5%N/A0.1 $15.15 4/30/202259,700 shares $905.65 thousand +69.1%N/A0.3 $15.17 4/15/202235,300 shares $580.69 thousand +451.6%N/A0.2 $16.45 3/31/20226,400 shares $99.71 thousand +220.0%N/A0 $15.58 3/15/20222,000 shares $31.32 thousand -75.3%N/A0 $15.66 2/28/20228,100 shares $135.11 thousand -77.7%N/A0 $16.68 2/15/202236,300 shares $627.05 thousand -17.7%N/A0.2 $17.27 1/31/202244,100 shares $712.22 thousand -4.8%N/A0.2 $16.15 1/15/202246,300 shares $764.41 thousand +282.6%N/A0.3 $16.51 12/31/202112,100 shares $196.87 thousand -55.4%N/A0.1 $16.27 12/15/202127,100 shares $431.16 thousand -13.1%N/A0.1 $15.91 11/30/202131,200 shares $485.32 thousand -50.9%N/A0.2 $15.56 11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37 10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88 10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55 9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 9/15/202137,000 shares $629 thousand +380.5%N/A0.4 $17.00 8/31/20217,700 shares $129.21 thousand +3,750.0%N/A0.1 $16.78 8/13/2021200 shares $3.25 thousand -97.2%N/A0 $16.23 7/30/20217,200 shares $114.62 thousand -36.8%N/A0.1 $15.92 7/15/202111,400 shares $198.47 thousand -81.7%N/A0.1 $17.41 6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38 6/15/202151,600 shares $904.55 thousand -28.3%N/A0.3 $17.53 5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22 5/14/202114,100 shares $215.17 thousand +1,914.3%N/A0.1 $15.26 4/30/2021700 shares $10.46 thousand -82.1%N/A0 $14.95 4/15/20213,900 shares $58.81 thousand -76.4%N/A0 $15.08 3/31/202116,500 shares $258.06 thousand +66.7%N/A0.2 $15.64 3/15/20219,900 shares $164.84 thousand -73.9%N/A0.1 $16.65 2/26/202137,900 shares $626.11 thousand -41.4%N/A0.5 $16.52 2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99 1/29/202111,500 shares $188.37 thousand -85.3%N/A0.1 $16.38 1/15/202140,400 shares $642.76 thousand -34.0%N/A0.2 $15.91 12/31/202017,600 shares $271.04 thousand -56.4%N/A0.1 $15.40 12/15/202040,400 shares $589.44 thousand -34.0%N/A0.2 $14.59 11/30/202061,200 shares $954.11 thousand +367.2%N/A0.5 $15.59 11/15/202013,100 shares $203.31 thousand +718.8%N/A0.1 $15.52 10/30/20201,600 shares $22.26 thousand -88.8%N/A0 $13.91 10/15/202014,300 shares $202.49 thousand +44.4%N/A0.1 $14.16 9/30/20209,900 shares $147.61 thousand +125.0%N/A0.1 $14.91 9/15/20204,400 shares $67.06 thousand -91.3%N/A0 $15.24 8/31/202050,800 shares $796.04 thousand +681.5%N/A0.4 $15.67 8/14/20206,500 shares $106.34 thousand -59.4%N/A0.1 $16.36 ALPMY Short Interest - Frequently Asked Questions What is Astellas Pharma's current short interest? Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 350,400 shares of ALPMY short. Learn More on Astellas Pharma's current short interest. What is a good short interest ratio for Astellas Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALPMY shares currently have a short interest ratio of 1.0. Learn More on Astellas Pharma's short interest ratio. Is Astellas Pharma's short interest increasing or decreasing? Astellas Pharma saw a increase in short interest in July. As of July 15th, there was short interest totaling 350,400 shares, an increase of 1,252.9% from the previous total of 25,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Astellas Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "med - drugs" compare to Astellas Pharma: GlobeStar Therapeutics Corporation (0.00%), Indivior PLC (7.89%), MEI Pharma, Inc. (0.27%), Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (0.00%), Zoetis Inc. (1.76%), Daiichi Sankyo Co., Ltd. - Sponsored ADR (0.00%), and Takeda Pharmaceutical Co. (0.14%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Astellas Pharma stock? Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. ALPMY shares are trading up $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astellas Pharma? A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further. How often is Astellas Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies AOBI Short Interest GSTC Short Interest INDV Short Interest MEIP Short Interest MRVT Short Interest OASMY Short Interest RNUGF Short Interest UCBJY Short Interest CHGCY Short Interest ZTS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ALPMY) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astellas Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
